GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Allgens Medical Technology Co 688613.SS · CNY

Health Care · Shanghai · 🇨🇳 China

Compare

7.90

-3.07%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Allgens Medical Technology Co

Its shares trade on Shanghai under the ticker 688613.SS. It has been listed since 21 May 2021. In the fiscal year to 31 December 2025, it reported revenue of CN¥223.5m and net income of CN¥13.2m. At that date it held total assets of CN¥1.56bn and shareholders' equity of CN¥1.43bn.

Allgens Medical Technology Co., Ltd. engages in the research, development, production, and sale of biomedical materials and related medical device products. The company is headquartered in Beijing, Beijing. The company went IPO on 2021-05-21. The Company’s main products are mineralized collagen artificial bone repair products used in orthopedics, oral or plastic surgery, and neurosurgery, including Gejin and BonGold, which are mainly used for filling and regenerative repair of various bone defects in the orthopedics field. Chibei, which are mainly used for filling and regenerating bone defects in oral and orthopedic surgery. And Lurui, which are mainly used for cranial defect filling and regeneration repair in neurosurgery. The firm distributes its products both in the domestic market and to overseas markets.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Equipment & Supplies
Listed since
21 May 2021
Employees
151

Leadership

Pay as last reported

  • Mr. Gang HuChairman of the Board, since 2022
  • Mr. Tainxi SongChief Financial Officer, Chief Research & Development Officer
  • Mr. Menglong CuiGeneral Manager
  • Mr. Zhiye ChouSecretary of the Board

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Allgens Medical Technology Co Ltd focuses on biomedical materials and medical devices in Beijing, China.
  • Gejin and BonGold are key products for bone defect repair in orthopedics and oral surgery.
  • Chibei and Lurui address specific bone repair needs in oral, orthopedic, and neurosurgery fields.

Weaknesses

  • The company has only 151 employees, which may limit operational capacity.
  • Allgens operates primarily in the Chinese market with limited international presence.
  • The company's IPO in 2021 may indicate early-stage financial constraints.

Opportunities

  • Expanding into overseas markets could increase product reach and revenue.
  • Growing demand for bone repair products in the Health Care sector presents opportunities.
  • The Health Care industry in China continues to expand rapidly.

Threats

  • Competition from established medical device companies in the Health Care sector is intense.
  • Regulatory changes in the Chinese Health Care industry could impact operations.
  • Economic downturns may reduce healthcare spending and affect sales.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.